Continuous and Daily Oral Immunotherapy for Peanut Allergy: Results from a 2-Year Open-Label Follow-On Study

The randomized, controlled PALISADE trial demonstrated the benefit of daily oral immunotherapy with Peanut (Arachis Hypogaea) allergen powder-dnfp (PTAH, formerly AR101) in peanut-allergic children and adolescents.ARC004, the open-label follow-on study to PALISADE, used 5 dosing cohorts to explore P...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Brian P. Vickery, Andrea Vereda, Caroline Nilsson, George Du Toit, Wayne G. Shreffler, A. Wesley Burks, Stacie M. Jones, Montserrat Fernández‐Rivas, Katharina Blümchen, Jonathan O’B Hourihane, Kirsten Beyer, Aikaterini Anagnostou, Amal Assa’ad, Moshe Ben‐Shoshan, J. Andrew Bird, Tara F. Carr, Warner Carr, Thomas B. Casale, Hey Chong, Christina E. Ciaccio, Morna J. Dorsey, Stanley M. Fìneman, Stephen B. Fritz, Alexander N. Greiner, Leon S. Greos, Frank C. Hampel, María Ibáñez-Vea, David Jeong, Douglas Johnston, Rita Kachru, Edwin Kim, Bruce J. Lanser, Stephanie A. Leonard, Mary C. Maier, Lyndon E. Mansfield, Antonella Muraro, Jason Ohayon, J. N. G. Oude Elberink, Daniel Petroni, Jacqueline A. Pongracic, Jay M. Portnoy, Rima Rachid, Ned T. Rupp, Georgiana Sanders, Hemant Sharma, Vibha Sharma, Ellen Sher, Lawrence Sher, Sayantani Sindher, Dareen Siri, Jonathan M. Spergel, A. B. Sprikkelman, Gordon L. Sussman, Marina Tsoumani, Pooja Varshney, Girish Vitalpur, Julie Wang, William H. Yang, José Manuel Zubeldia, Alex Smith, Robert Ryan, Daniel C. Adelman
Formaat: Artigo
Taal:Engels
Gepubliceerd in: 2020
Online toegang:https://doi.org/10.1016/j.jaip.2020.12.029
http://www.jaci-inpractice.org/article/S2213219820313611/pdf
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items